Prostaglandin EP3 receptor superactivates adenylyl cyclase via the Gq/PLC/Ca2+ pathway in a lipid raft-dependent manner

Biochem Biophys Res Commun. 2009 Nov 27;389(4):678-82. doi: 10.1016/j.bbrc.2009.09.064. Epub 2009 Sep 19.

Abstract

We previously demonstrated that prostaglandin EP3 receptor augments EP2-elicited cAMP formation in COS-7 cells in a G(i/o)-insensitive manner. The purpose of our current study was to identify the signaling pathways involved in EP3-induced augmentation of receptor-stimulated cAMP formation. The enhancing effect of EP3 receptor was irrespective of the C-terminal structure of the EP3 isoform. This EP3 action was abolished by treatment with inhibitors for phospholipase C and intracellular Ca(2+)-related signaling molecules such as U73122, staurosporine, 2-APB and SK&F 96365. Indeed, an EP3 agonist stimulated IP(3) formation and intracellular Ca(2+) mobilization, which was blocked by U73122, but not by pertussis toxin. The enhancing effect by EP3 on cAMP formation was mimicked by both a Ca(2+) ionophore and the activation of a typical G(q)-coupled receptor. Moreover, EP3 was exclusively localized to the raft fraction in COS-7 cells and EP3-elicited augmentation of cAMP formation was abolished by cholesterol depletion and introduction of a dominant negative caveolin-1 mutant. These results suggest that EP3 elicits adenylyl cyclase superactivation via G(q)/phospholipase C activation and intracellular Ca(2+) mobilization in a lipid raft microdomain-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / biosynthesis*
  • Animals
  • Boron Compounds / pharmacology
  • COS Cells
  • Calcium / metabolism*
  • Caveolin 1 / metabolism
  • Chlorocebus aethiops
  • Enzyme Activation
  • Estrenes / pharmacology
  • GTP-Binding Protein alpha Subunits, Gq-G11 / metabolism*
  • Humans
  • Imidazoles / pharmacology
  • Ionophores / pharmacology
  • Membrane Microdomains / metabolism*
  • Pyrrolidinones / pharmacology
  • Receptors, Prostaglandin E / antagonists & inhibitors
  • Receptors, Prostaglandin E / metabolism*
  • Receptors, Prostaglandin E, EP2 Subtype
  • Staurosporine / pharmacology
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism*

Substances

  • 2-aminoethyl diphenylborinate
  • Boron Compounds
  • Caveolin 1
  • Estrenes
  • Imidazoles
  • Ionophores
  • PTGER2 protein, human
  • Pyrrolidinones
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP2 Subtype
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Type C Phospholipases
  • GTP-Binding Protein alpha Subunits, Gq-G11
  • Adenylyl Cyclases
  • Staurosporine
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole
  • Calcium